Brief: Nykode Therapeutics Q4 Total Revenue And Other Income At USD 6.9 Million
Feb 26 (Reuters) - Nykode Therapeutics ASA NYKD.OL: Q4 TOTAL REVENUE AND OTHER INCOME OF USD 6.9 MILLION Q4 NET LOSS OF USD 6.8 MILLION Source text: ID:nObi5cTyqa Further company coverage: NYKD.OL (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Nykode Therapeutics ASA
See all newsRCS - Accession Theraptcs. - Accession Therapeutics: Board appointments
Brief: Nykode Therapeutics Mulls Private Placement
Brief: Nykode Receives Draft Recommendation In Tax Case
Brief: Nykode Therapeutics Receives U.S. Vaccine Patent
Brief: Nykode Therapeutics Expects Draft Recommendation From Norwegian Tax Appeal Board In August 2026